STUB1 and hematopoietic and lymphoid system neoplasm: For example, Jaiswal et al. estimated that the presence of CHIP conferred a 0.5% per year risk for developing a hematological neoplasm, which increased to 1% per year if the VAF exceeded 10% [34].